Novorex Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $14M

  • Investors
  • 18

Novorex General Information

Description

Developer of a small-molecule therapeutics platform designed to discover treatments for neurological and immune-mediated diseases. The company offers artificial intelligence-driven molecular design, fragment-based drug discovery, structural biology, and biophysical validation using nuclear magnetic resonance, surface plasmon resonance, and X-ray crystallography, enabling pharmaceutical and biotechnology companies to identify drug candidates targeting challenging disease mechanisms, including Parkinson's disease and inflammatory disorders.

Contact Information

Website
www.novorex.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 240 Pangyoyeok-ro
  • Bundang-gu
  • Seongnam-si, Gyeonggi-do 13493
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 240 Pangyoyeok-ro
  • Bundang-gu
  • Seongnam-si, Gyeonggi-do 13493
  • South Korea

Novorex Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novorex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 09-Apr-2026 $14M Completed Clinical Trials - Phase 1
5. Early Stage VC (Series A) 20-Nov-2023 Completed Startup
4. Early Stage VC (Series A) 21-Jul-2021 Completed Startup
3. Accelerator/Incubator 01-Mar-2020 Completed Startup
2. Seed Round 29-Feb-2020 $1.34M $1.34M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Novorex’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Novorex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a small-molecule therapeutics platform designed to discover treatments for neurological and immune-mediated
Drug Discovery
Seongnam-si, South Korea
33 As of 2026

Berwyn, PA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novorex Competitors (1)

One of Novorex’s competitors is Vernalis Therapeutics, a Corporation company based in Berwyn, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vernalis Therapeutics Corporation Berwyn, PA
You’re viewing 1 of 1 competitors. Get the full list »

Novorex Patents

Novorex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025219272-A1 Novel compounds as lrrk2 protein kinase domain inhibitors Pending 07-Feb-2024
WO-2025170397-A1 Novel compounds as lrrk2 protein kinase domain inhibitors Pending 07-Feb-2024
WO-2024076155-A1 Novel compound as yeats domain inhibitor Inactive 04-Oct-2022

Novorex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novorex Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hyundai Technology Investment Venture Capital Minority
K&N Investment Partners Corporation Minority
Korea Development Bank PE/Buyout Minority
SBI Investment Venture Capital Minority
Solidus Investment Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Novorex FAQs

  • When was Novorex founded?

    Novorex was founded in 2020.

  • Where is Novorex headquartered?

    Novorex is headquartered in Seongnam-si, South Korea.

  • What is the size of Novorex?

    Novorex has 33 total employees.

  • What industry is Novorex in?

    Novorex’s primary industry is Drug Discovery.

  • Is Novorex a private or public company?

    Novorex is a Private company.

  • What is the current valuation of Novorex?

    The current valuation of Novorex is .

  • What is Novorex’s current revenue?

    The current revenue for Novorex is .

  • How much funding has Novorex raised over time?

    Novorex has raised $33.2M.

  • Who are Novorex’s investors?

    Hyundai Technology Investment, K&N Investment Partners, Korea Development Bank, SBI Investment, and Solidus Investment are 5 of 18 investors who have invested in Novorex.

  • Who are Novorex’s competitors?

    Vernalis Therapeutics is a competitor of Novorex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process